Alginate-coated chitosan nanoparticles for pH-dependent release of tamoxifen citrate

References

• Ghahremani F, Shahbazi-Gahrouei D, Kefayat A, et al. AS1411 aptamer conjugated gold nanoclusters as a targeted radiosensitizer for megavoltage radiation therapy of 4T1 breast cancer cells. RSC Adv. 2018;8(8):4249–4258.
   Google Scholar
• Cabeza L, Ortiz R, Arias JL, et al. Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly (butylcyanoacrylate) nanoparticles. Int J Nanomed. 2015;10:1291–1306.
   Google Scholar
• Bhurgri Y. Karachi cancer registry data–implications for the national cancer control program of pakistan. Asian Pac J Cancer Prev. 2004;5(1):77–82.
   Google Scholar
• Akram M, Iqbal M, Daniyal M, et al. Awareness and current knowledge of breast cancer. Biol Res. 2017;50(1):33.
   Google Scholar
• Tagde P, Kulkarni G, Mishra DK, et al. Recent advances in folic acid engineered nanocarriers for treatment of breast cancer. J Drug Delivery Sci Technol. 2020;56:101613.
   Google Scholar
• Yezhelyev MV, Gao X, Xing Y, et al. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol. 2006;7(8):657–667.
   Google Scholar
• Nag M, Gajbhiye V, Kesharwani P, et al. Transferrin functionalised chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells. Colloids Surf B Biointerfaces. 2016;148:363–370.
   Google Scholar
• Abriata JP, Turatti RC, Luiz MT, et al. Development, characterisation and biological in vitro assays of paclitaxel-loaded PCL polymeric nanoparticles. Mater Sci Eng C Mater Biol Appl. 2019;96:347–355.
   Google Scholar
• Martinez A, Arana P, Fernández A, et al. Synthesis and characterisation of alginate/chitosan nanoparticles as tamoxifen controlled delivery systems. J Microencapsul. 2013;30(4):398–408.
   Google Scholar
• Prabaharan M. Chitosan-based nanoparticles for tumour-targeted drug delivery. Int J Biol Macromol. 2015;72:1313–1322.
   Google Scholar
• Sun Y, Yu B, Wang G, et al. Enhanced antitumor efficacy of vitamin E TPGS-emulsified PLGA nanoparticles for delivery of paclitaxel. Colloids Surf B Biointerfaces. 2014;123:716–723.
   Google Scholar
• Gogoi P, Dutta A, Ramteke A, et al. Preparation, characterisation and cytotoxic applications of curcumin‐(±) α‐lipoic acid coloaded phosphorylated chitosan nanoparticles in MDA MB 231 breast cancer cell line. Polym Adv Technol. 2020;31(11):2827–2841.
   Google Scholar
• Naskar S, Koutsu K, Sharma S. Chitosan-based nanoparticles as drug delivery systems: a review on two decades of research. J Drug Target. 2019;27(4):379–393.
   Google Scholar
• Katuwavila NP, Perera A, Samarakoon SR, et al. Chitosan-alginate nanoparticle system efficiently delivers doxorubicin to MCF-7 cells. J Nanomater. 2016;2016:1–12.
   Google Scholar
• Bagre AP, Jain K, Jain NK. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Int J Pharm. 2013;456(1):31–40.
   Google Scholar
• Criado-Gonzalez M, Fernandez-Gutierrez M, San Roman J, et al. Local and controlled release of tamoxifen from multi (layer-by-layer) alginate/chitosan complex systems. Carbohydr Polym. 2019;206:428–434.
   Google Scholar
• Martinez A, Muniz E, Teijon C, et al. Targeting tamoxifen to breast cancer xenograft tumours: preclinical efficacy of folate-attached nanoparticles based on alginate-cysteine/disulphide-bond-reduced albumin. Pharm Res. 2014;31(5):1264–1274.
   Google Scholar
• Ravikumara NR, Madhusudhan B. Chitosan nanoparticles for tamoxifen delivery and cytotoxicity to MCF-7 and vero cells. Pure Appl Chem. 2011;83(11):2027–2040.
   Google Scholar
• Albert EL, Shirosaki Y, Abdullah CAC. Drug release and kinetic study of tamoxifen citrate conjugated with magnetite nanoparticle for drug delivery application. IJAER. 2018;13:5360–5369.
   Google Scholar
• Buckley MM, Goa KL. Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use. Drugs. 1989;37(4):451–490. Apr
   Google Scholar
• Tukker JJ, Blankenstein MA, Nortier JW. Comparison of bioavailability in man of tamoxifen after oral and rectal administration. J Pharm Pharmacol. 1986;38(12):888–892.
   Google Scholar
• Bhagwat GS, Athawale RB, Gude RP, et al. Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy. Front Pharmacol. 2020;11:614290. PMID: 33329007; PMCID: PMC7729133.
   Google Scholar
• Tığlı Aydın RS, Pulat M. 5-Fluorouracil encapsulated chitosan nanoparticles for pH-stimulated drug delivery: evaluation of controlled release kinetics. J Nanomater. 2012;2012:1–10.
   Google Scholar
• Wei W, Lv P-P, Chen X-M, et al. Codelivery of mTERT siRNA and paclitaxel by chitosan-based nanoparticles promoted synergistic tumour suppression. Biomaterials. 2013;34(15):3912–3923.
   Google Scholar
• Yang R, Yang S-G, Shim W-S, et al. Lung-specific delivery of paclitaxel by chitosan-modified PLGA nanoparticles via transient formation of microaggregates. J Pharm Sci. 2009;98(3):970–984.
   Google Scholar
• Li F, Li J, Wen X, et al. Anti-tumour activity of paclitaxel-loaded chitosan nanoparticles: an in vitro study. Mater Sci Eng C. 2009;29(8):2392–2397.
   Google Scholar
• Vivek R, Babu VN, Thangam R, et al. pH-responsive drug delivery of chitosan nanoparticles as tamoxifen carriers for effective anti-tumour activity in breast cancer cells. Colloids Surf B Biointerfaces. 2013;111:117–123.
   Google Scholar
• Md S, Abdullah S, Alhakamy NA, et al. Development, optimization, and in vitro evaluation of novel oral Long-Acting resveratrol nanocomposite in-Situ gelling film in the treatment of colorectal cancer. Gels. 2021;7(4):276.
   Google Scholar
• Rampino A, Borgogna M, Blasi P, et al. Chitosan nanoparticles: preparation, size evolution and stability. Int J Pharm. 2013;455(1–2):219–228.
   Google Scholar
• Konecsni K, Low N, Nickerson M. Chitosan–tripolyphosphate submicron particles as the carrier of entrapped rutin. Food Chem. 2012;134(4):1775–1779.
   Google Scholar
• Nasti A, Zaki NM, De Leonardis P, et al. Chitosan/TPP and chitosan/TPP-hyaluronic acid nanoparticles: systematic optimisation of the preparative process and preliminary biological evaluation. Pharm Res. 2009;26(8):1918–1930.
   Google Scholar
• Yang W, Fu J, Wang T, et al. Chitosan/sodium tripolyphosphate nanoparticles: preparation, characterisation and application as drug carrier. J Biomed Nanotechnol. 2009;5(5):591–595.
   Google Scholar
• Grenha A, Seijo B, Remunán-López C. Microencapsulated chitosan nanoparticles for lung protein delivery. Eur J Pharm Sci. 2005;25(4-5):427–437.
   Google Scholar
• Hu B, Pan C, Sun Y, et al. Optimisation of fabrication parameters to produce chitosan − tripolyphosphate nanoparticles for delivery of tea catechins. J Agric Food Chem. 2008;56(16):7451–7458.
   Google Scholar
• Chen G, Zhao Y, Xu Y, et al. Chitosan nanoparticles for oral photothermally enhanced photodynamic therapy of Colon cancer. Int J Pharm. 2020;589:119763.
   Google Scholar
• Wang JJ, Zeng ZW, Xiao RZ, et al. Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomed. 2011;6:765–774.
   Google Scholar
• Patel BK, Parikh RH, Aboti PS. Development of oral sustained release rifampicin loaded chitosan nanoparticles by design of experiment. J Drug Deliv. 2013;2013:370938.
   Google Scholar